SCHEMBL6507463

SCHEMBL6507463

COc1c(N2CCC(C3(N(C)CCC#N)CC3)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KCNH2 Q12809 5/20 0.63
KDM4E B2RXH2 9/20 0.59
ALDH1A1 P00352 5/20 0.59
HPGD P15428 4/20 0.59
POLB P06746 3/20 0.59
HSD17B10 Q99714 2/20 0.59
TDP1 Q9NUW8 2/20 0.59
OPRM1 P35372 2/20 0.59
PRKD3 O94806 1/20 0.59
ALOX15 P16050 1/20 0.59
CLK2 P49760 1/20 0.59
CLK4 Q9HAZ1 1/20 0.59
LMNA P02545 2/20 0.55
MEN1 O00255 1/20 0.52
KMT2A Q03164 1/20 0.52
NPSR1 Q6W5P4 1/20 0.52
CYP2C19 P33261 1/20 0.51
L3MBTL1 Q9Y468 1/20 0.51
ATM Q13315 1/20 0.51
CHRM2 P08172 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6530268 0.95 KCNH2 (0.59) KCNH2KDM4EALDH1A1HPGDPOLB
SCHEMBL6529826 0.92 KCNH2 (0.64) KCNH2KDM4EALDH1A1HPGDPOLB
SCHEMBL6528606 0.87 KCNH2 (0.60) KCNH2KDM4EALDH1A1HPGDPOLB
SCHEMBL6502365 0.86 KCNH2 (0.64) KCNH2KDM4EALDH1A1HPGDPOLB
SCHEMBL6528792 0.86 KCNH2 (0.61) KCNH2KDM4EALDH1A1HPGDPOLB
SCHEMBL6509139 0.86 KCNH2 (0.67) KCNH2KDM4EALDH1A1HPGDPOLB
SCHEMBL1155437 0.83 KDM4E (0.65) KCNH2KDM4EALDH1A1HPGDPOLB
SCHEMBL6527488 0.83 KCNH2 (0.72) KCNH2KDM4EALDH1A1HPGDPOLB
SCHEMBL6474352 0.83 KCNH2 (0.72) KCNH2KDM4EALDH1A1HPGDPOLB
SCHEMBL6508139 0.82 KCNH2 (0.60) KCNH2KDM4EALDH1A1HPGDPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2005051381-A1 Substituted urea-octatydroindols as antagonists of melanin concentrating hormone receptor 1 (MCH1R) BIOVITRUM AB (SE) 2005-06-09 WO disclosed
WO-2005049602-A1 QUINOLONE ANTIBACTERIAL AGENTS WARNER-LAMBERT COMPANY LLC (US) 2005-06-02 WO disclosed
WO-2005023189-A2 METHOD OF COX-2 SELECTIVE INHIBITOR AND NITRIC OXIDE-DONATING AGENT PHARMACIA CORPORATION (US) 2005-03-17 WO disclosed